NCT03886181View on ClinicalTrials.gov

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

October 31, 2025

Conditions
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Interventions
DEVICE

Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of a seed(s), loaded with Radium-224, securely fixed in the seeds. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Trial Locations (1)

Unknown

RECRUITING

IRCCS Istituto Dermatologico S. Gallicano, IFO - Istituti Fisioterapici Ospitalieri - Dermatologia Oncologica e Prevenzione, Rome

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY